Onset of azoospermia in man treated with ipilimumab/nivolumab for BRAF negative metastatic melanoma

Onset of azoospermia in man treated with ipilimumab/nivolumab for BRAF negative metastatic melanoma

Azoospermia is classified as the complete absence of sperm in ejaculate and accounts for 10–15% of male infertility. Many anticancer drugs are known to cause defects in spermatogenesis, but the effects of immune checkpoint inhibitor cancer therapy on spermatogenesis remains largely unknown. Presente...

Full description

Bibliographic Details
Main Authors: Matthew J. Rabinowitz, Taylor P. Kohn, Vanessa N. Peña, Iryna V. Samarska, Andres Matoso, Amin S. Herati
Format: Article
Language:English
Published: Elsevier 2021-01-01
Series:Urology Case Reports
Subjects:
Infertility
Male
Azoospermia
BRAF
immune Checkpoint inhibitor therapy
Immunotherapy
Online Access:http://www.sciencedirect.com/science/article/pii/S2214442020303776

Internet

http://www.sciencedirect.com/science/article/pii/S2214442020303776

Similar Items